A study published today in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, ...

At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions  SAN DIEGO, Feb. 26, 2026 ...

Hidden within cancer DNA data, researchers uncovered viruses and bacteria that may influence both diagnosis and survival.

A fleeting DNA fold called i‑DNA can switch cancer‑related genes on and off, revealing a hidden structural weak point that ...

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

Cancer genomics pioneer Prof Sir Mike Stratton has been awarded the 2026 Jessie Stevenson Kovalenko Medal by the Council of ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...

International team uncovers gene mutations that cause rare and aggressive cancer in both cats and humans. Their findings ...